References

[1]     Mattsson S, Johansson L, Leide Svegborn S, Liniecki J, Noßke D, Riklund KÅ, et al. ICRP Publication 128: Radiation Dose to Patients from Radiopharmaceuticals: a Compendium of Current Information Related to Frequently Used Substances. Ann ICRP 2015;44:7–321. https://doi.org/10.1177/0146645314558019.

[2]     Majd M, Bar-Sever Z, Santos AI, De Palma D. The SNMMI and EANM Procedural Guidelines for Diuresis Renography in Infants and Children. J Nucl Med 2018;59:1636–40. https://doi.org/10.2967/jnumed.118.215921.

[3]     EANM. EANM Paediatrics Guidelines. n.d.

[4]     Blaufox MD, Aurell M, Bubeck B, Fommei E, Piepsz A, Russell C, et al. Report of the Radionuclides in Nephrourology Committee on renal clearance. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 1996;37:1883–90. PMID: 8917197

[5]     Prigent A, Cosgriff P, Gates GF, Granerus G, Fine EJ, Itoh K, et al. Consensus report on quality control of quantitative measurements of renal function obtained from the renogram: International Consensus Committee from the Scientific Committee of Radionuclides in Nephrourology. Seminars in Nuclear Medicine 1999;29:146–59. 10.1016/s0001-2998(99)80005-1

[6]     Taylor AT. Radionuclides in Nephrourology, Part 1: Radiopharmaceuticals, Quality Control, and Quantitative Indices. Journal of Nuclear Medicine 2014;55:608–615. https://doi.org/10.2967/jnumed.113.133447.10.2967/jnumed.113.133447

[7]     Farhat W, Traubici J, Sherman C, Williams T, Babyn P, Mclorie G. Reliability of Contrast Enhanced Sonography with Harmonic Imaging for Detecting Early Renal Scarring in Experimental Pyelonephritis in a Porcine Model: Preliminary Results. The Journal of Urology 2002;168:1114–1117. https://doi.org/10.1016/S0022-5347(05)64603-4. 

[8]     Sinha MD, Gibson P, Kane T, Lewis MA. Accuracy of ultrasonic detection of renal scarring in different centres using DMSA as the gold standard n.d. https://doi.org/10.1093/ndt/gfm155. 

[9]     ICRP. ICRP Publication 53. Radiation dose to patients from radiopharmaceuticals. Annals ICRP 1988;18.

[10]     ICRP. ICRP Publication 106. Radiation Dose to Patients from Radiopharmaceuticals - Addendum 3 to ICRP Publication 53. Annals ICRP 2008;38.

[11]     Majd M, Nussbaum Blask AR, Markle BM, Shalaby-Rana E, Pohl HG, Park J-S, et al. Acute Pyelonephritis: Comparison of Diagnosis with 99m Tc-DMSA SPECT, Spiral CT, MR Imaging, and Power Doppler US in an Experimental Pig Model. Radiology 2001;218:101–108. https://doi.org/10.1148/radiology.218.1.r01ja37101.

[12]     Pasini A, Benetti E, Conti G, Ghio L, Lepore M, Massella L, et al. The Italian Society for Pediatric Nephrology (SINePe) consensus document on the management of nephrotic syndrome in children: Part I - Diagnosis and treatment of the first episode and the first relapse. Italian Journal of Pediatrics 2017;43:41. https://doi.org/10.1186/s13052-017-0356-x.

[13]     Snow BW, Taylor MB. Non-invasive vesicoureteral reflux imaging. Journal of Pediatric Urology 2010;6:543–549. https://doi.org/10.1016/j.jpurol.2010.02.211.

[14]     Unver T, Alpay H, Biykli N, Ones T. Comparison of direct radionuclide cystography and voiding cystourethrography in detecting vesicoureteral reflux. Pediatrics International 2006;48:287–291. https://doi.org/10.1111/j.1442-200X.2006.02206.x.

[15]     Stabin MG, Gelfand MJ. Dosimetry of pediatric nuclear medicine procedures. The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 1998;42:93–112.

[16]     Fettich J, Colarinha P, Fischer S, Frökier J, Gordon I, Hahn K, et al. GUIDELINES FOR DIRECT RADIONUCLIDE CYSTOGRAPHY IN CHILDREN Under the Auspices of the Paediatric Committee of the European Association of Nuclear Medicine n.d. https://doi.org/10.1007/s00259-003-1137-x

[17]   MunariMouthaan BE, Rados M, Barsi P, Boon P, Carmichael DW, Carrette E, et al. Current use of imaging and electromagnetic source localization procedures in epilepsy surgery centers across Europe. Epilepsia 2016;57:770–776. https://doi.org/10.1111/epi.13347.

[18]   Guidelines for Neuroimaging Evaluation of Patients with Uncontrolled Epilepsy Considered for Surgery. Commission on Neuroimaging of the International League Against Epilepsy*. Epilepsia 1998;39:1375–1376. https://doi.org/10.1111/j.1528-1157.1998.tb01341.x.

[19]     Prigent A. Monitoring Renal Function and Limitations of Renal Function Tests. Seminars in Nuclear Medicine 2008;38:32–46. https://doi.org/10.1053/j.semnuclmed.2007.09.003.

[20]     Prigent A, Piepsz A. Functional Imaging in Nephro-Urology | Taylor & Francis Group. 1st Edition. London: CRC Press; 2006.

[21]     Rehling M, Mqller ML, Thamdrup B, Lund A N J 0, Trap-Jensen DJ. Simultaneous measurement of renal clearance and plasma clearance of gh " Tc-labelled diethylenetriaminepenta-acetate, %4abelled ethylenediaminetetra-acetate aqd inulin in man. Clinical Science 1984;66:613–619.

[22]     Blaufox MD, Aurell M, Bubeck B, Fommei E, Piepsz A, Russell C, et al. Report of the Radionuclides in Nephrourology Committee on renal clearance. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 1996;37:1883–90.

[23]     Moore A, Park-Holohan S-J, Blake G, Fogelman I. Conventional measurements of GFR using 51 Cr-EDTA overestimate true renal clearance by 10 percent. European Journal of Nuclear Medicine and Molecular Imaging 2003;30:4–8. https://doi.org/10.1007/s00259-002-1007-y.

[24]     Garnett ES, Parsons V, Veall N. Measurement of Glomerular Filtration-Rate in Man Using a 51CR/Edetic-Acid Complex. The Lancet 1967;289:818–819. https://doi.org/10.1016/S0140-6736(67)92781-X.

[25]     Fleming JS, Zivanovic MA, Blake GM, Burniston M, Cosgriff PS, British Nuclear Medicine Society. Guidelines for the measurement of glomerular filtration rate using plasma sampling. Nuclear Medicine Communications 2004;25:759–69.

[26]     Piepsz, A, Colarinha, P, Gordon, I, Hahn, K, Olivier, P, Sixt, R, et al. Guidelines for glomerular filtration rate determination in children. EJNMMI 2001;28:BP31-6.

[27]     Saha GB. Fundamentals of Nuclear Pharmacy. Cham: Springer International Publishing; 2018. https://doi.org/10.1007/978-3-319-57580-3.

[28]     Treves ST, editor. Pediatric Nuclear Medicine and Molecular Imaging. 4th ed. New York: Springer-Verlag; 2014. https://doi.org/10.1007/978-1-4614-9551-2.

[29]     Fleming JS, Wilkinson J, Oliver RM, Ackery DM, Blake GM, Waller DG. Comparison of radionuclide estimation of glomerular filtration rate using technetium 99m diethylenetriaminepentaacetic acid and chromium 51 ethylenediaminetetraacetic acid. European Journal of Nuclear Medicine 1991;18:391–395. https://doi.org/10.1007/BF02258429.

[30]     Biggi A, Viglietti A, Farinelli MC, Bonada C, Camuzzini G. Estimation of glomerular filtration rate and technetium-99m diethylene triamine penta-acetic acid using chromium-51 ethylene diamine tetra-acetic acid. European Journal of Nuclear Medicine 1995;22:532–536. https://doi.org/10.1007/BF00817277.

[31]     EANM. EANM Paediatrics Guidelines. N.d.

[32]     Peters AM. Quantification of renal haemodynamics with radionuclides. European Journal of Nuclear Medicine 1991;18:274–286. https://doi.org/10.1007/BF00186653.

[33]     Blaufox MD, Merrill JP. Simplified hippuran clearance. Measurement of renal function in man with simplified hippuran clearances. Nephron 1966;3:274–81. https://doi.org/10.1159/000179542.

[34]     Mackay A, Eadie AS, Cumming AMM, Graham AG, Adams FG, Horton PW. Assessment of total and divided renal plasma flow by 1231-hippuran renography. Kidney International 1981;19:49–57. https://doi.org/10.1038/ki.1981.6.

[35]     Bagni B, Bagni I, Orsolon P, Corazzari T. How Gender and Age Affect Iodine-131-OIH and Technetium-99m-MAG3 Clearance. J Nucl Med Technol 2000;28:156–158.

[36]     Tauxe WN, Dubovsky EvaV, Kidd T, Diaz F, Smith LR. New formulas for the calculation of effective renal plasma flow. European Journal of Nuclear Medicine 1982;7:51–54. https://doi.org/10.1007/BF00251641.

[37]     Blaufox MD, De Palma D, Taylor A, Szabo Z, Prigent A, Samal M, et al. The SNMMI and EANM practice guideline for renal scintigraphy in adults. Eur J Nucl Med Mol Imaging 2018;45:2218–28. https://doi.org/10.1007/s00259-018-4129-6.

[38]     Bergmann, H, Mostbeck, A, Kletter, K. Empfehlungen zur Durchführung von nuklearmedizinischen Nierenfunktionsuntersuchungen mit Gammakamera und Computer. Acta Medica Austriaca 1991;43:Suppl 1-19.

[39]     Tonnesen, K, Munck, O, Hald, T. Influence on the renogram of variation in skin-to-kidney distance and the clinical importance thereof. Radionuclides in Nephrology, Stuttgart: Georg Thieme Verlag; 1975, p. 79–86.

[40]     Britton KE. Dynamic radionuclide imaging. Br Med Bull 1980;36:215–22. https://doi.org/10.1093/oxfordjournals.bmb.a071644.

[41]     Muncker, T. Renal Tixels. Computer Assisted Functional Analysis. 19. Internationale Jahrestagung der Gesellschaft für Nuklearmedizin, Schattauer Verlag; 1982, p. 151–5.

[42]     Agostini D, Roule V, Nganoa C, Roth N, Baavour R, Parienti J-J, et al. First validation of myocardial flow reserve assessed by dynamic 99mTc-sestamibi CZT-SPECT camera: head to head comparison with 15O-water PET and fractional flow reserve in patients with suspected coronary artery disease. The WATERDAY study. Eur J Nucl Med Mol Imaging 2018;45:1079–90. https://doi.org/10.1007/s00259-018-3958-7.

[43]     Britton KE, Gilday DL, Maisey M. Clinical Nuclear Medicine. Springer US; 1991. https://doi.org/10.1007/978-1-4899-3358-4.

[44]     Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med. 2001;344:431-42. doi: 10.1056/NEJM200102083440607.24549283 

[45]     Gornik HL, Persu A, Adlam D, Aparicio LS, Azizi M, Boulanger M, Bruno RM, de Leeuw P, Fendrikova-Mahlay N, Froehlich J, et al. First International Consensus on the diagnosis and management of fibromuscular dysplasia. Vasc Med. 2019;24:164–189. doi: 10.1177/1358863X211035538.

[44]     Stratigis S, Stylianou K, Kyriazis PP, Dermitzaki EK, Lygerou D, Syngelaki P, Stratakis S, Koukouraki S, Parthenakis F, Tsetis D, Daphnis E. Renal artery stenting for atherosclerotic renal artery stenosis identified in patients with coronary artery disease: Does captopril renal scintigraphy predict outcomes? J Clin Hypertens (Greenwich). 2018;20:373-381. doi: 10.1111/jch.13160.

[47]     Datseris IE, Bomanji JB, Brown EA, Nijran KS, Padhy AK, Siraj QH, Britton KE. Captopril renal scintigraphy in patients with hypertension and chronic renal failure. J Nucl Med. 1994. PMID: 8294993.

[48]     Taylor A. et al. Society of Nuclear Medicine and Molecular Imaging Procedure Guideline for Diagnosis of Renovascular Hypertension. Version 3.0, approved June 20,2003. https://snmmi.org/Web/Clinical-Practice/Procedure-Standards/Standards/Renovascular-Hypertension-3-0 (accessed 27.02.2025)

[49]     Protection IC on R. Radiation Dose to Patients from Radiopharmaceuticals (Addendum to ICRP Publication 53). Annals of the ICRP [Internet]. 1998;28(3). Available from: https://www.icrp.org/publication.asp?id=ICRP%20Publication%2080